Guilin Sanjin Pharmaceutical Co., Ltd. (SHE: 002275)
China flag China · Delayed Price · Currency is CNY
13.41
-0.16 (-1.18%)
Sep 10, 2024, 3:04 PM CST

Guilin Sanjin Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Market Capitalization
7,8688,5147,5709,7288,5777,643
Upgrade
Market Cap Growth
-31.09%12.46%-22.18%13.41%12.23%1.17%
Upgrade
Enterprise Value
6,9617,5546,5858,5057,3486,661
Upgrade
Last Close Price
13.3914.1812.4714.9112.3910.72
Upgrade
PE Ratio
22.9819.6922.2624.8525.8216.00
Upgrade
PS Ratio
3.853.923.865.595.484.66
Upgrade
PB Ratio
2.703.022.693.432.902.71
Upgrade
P/FCF Ratio
15.7518.0116.2336.5521.8531.56
Upgrade
P/OCF Ratio
12.9615.5014.3223.7114.3416.32
Upgrade
EV/Sales Ratio
3.403.483.364.884.694.06
Upgrade
EV/EBITDA Ratio
14.0013.5815.9820.5918.6711.98
Upgrade
EV/EBIT Ratio
17.6816.3220.8626.0623.4514.31
Upgrade
EV/FCF Ratio
13.9415.9814.1231.9518.7227.51
Upgrade
Debt / Equity Ratio
0.170.190.170.210.140.09
Upgrade
Debt / EBITDA Ratio
0.980.921.081.411.030.47
Upgrade
Debt / FCF Ratio
0.971.121.002.291.031.08
Upgrade
Asset Turnover
0.540.550.490.440.430.48
Upgrade
Inventory Turnover
2.142.412.171.912.422.74
Upgrade
Quick Ratio
2.752.092.392.563.604.40
Upgrade
Current Ratio
3.312.462.712.964.044.90
Upgrade
Return on Equity (ROE)
11.62%14.97%11.66%11.85%9.59%13.95%
Upgrade
Return on Assets (ROA)
6.49%7.32%4.89%5.11%5.37%8.53%
Upgrade
Return on Capital (ROIC)
7.14%8.73%5.86%5.99%6.08%9.72%
Upgrade
Earnings Yield
4.35%4.95%4.35%3.53%3.23%5.13%
Upgrade
FCF Yield
6.35%5.55%6.16%2.74%4.58%3.17%
Upgrade
Dividend Yield
4.48%4.23%6.42%6.04%3.23%2.15%
Upgrade
Payout Ratio
107.72%101.54%173.24%132.00%52.97%53.62%
Upgrade
Buyback Yield / Dilution
1.07%0.56%-2.72%0.74%1.39%0.88%
Upgrade
Total Shareholder Return
5.55%4.79%3.70%6.78%4.62%3.03%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.